ASX Announcements

    Adverse appeal decision in the US patent infringement case
    Cochlear withdraws FY20 earnings guidance due to coronavirus
    Appendix 2A
    HY20 Result Presentation Slides
    HY20 Result ASX & Media Release
    Dividend/Distribution - COH
    Half Yearly Report and Accounts
    Cochlear announces additional investment in Nyxoah
    Cochlear reduces earnings guidance due to coronavirus
    Initial Director's Interest Notice - Appendix 3X M G Daniell
    Change in substantial holding
    Appointment of Michael Daniell to the Cochlear Limited Board
    Appendix 3B
    FDA Clearance for Cochlear Osia 2 System
    Appendix 3B
    Appendix 3B
    Appendix 3B
    Appendix 3Y - Diggory Howitt
    Appendix 3B
    Appendix 3B
      Subscribe to Email Alerts